Hi, folks.

Slides:



Advertisements
Similar presentations
Insulin Therapy in Type 2 Diabetes: Current and Future Directions
Advertisements

Emma Harris Medicines Management Pharmacist West Suffolk Clinical Commissioning Group Educational Event 28 th January 2014 West Suffolk Hospital Education.
Diabetes Management: Different Treatments for Different Times
Diabetes Medications Update
Faculty Disclosure Mikayla Spangler, PharmD, BCPS Dr. Spangler has listed no financial interest/arrangement that would be considered a conflict of interest.
Implementing Diabetes Guidelines in the “Real World” Martin J. Abrahamson, MD FACP Associate Professor of Medicine, Harvard Medical School Senior Vice.
Canadian Diabetes Association Clinical Practice Guidelines Pharmacologic Management of Type 2 Diabetes Chapter 13 William Harper, Maureen Clement, Ronald.
New Perspectives in the Management of Type 2 Diabetes Herold Merisier, MD, FAAFP Voluntary Assistant Professor of Family Medicine Miller School of Medicine,
Case Management and Diabetes Mellitus Shirley Descheenie-Effland, RN Suzanne Lipke, APRN, BC-ADM, CDE Charlton Wilson, MD.
© Copyright Annals of Internal Medicine, 2015 Ann Int Med. 162 (3): ITC3-1. * For Best Viewing: Open in Slide Show Mode Click on icon or From the View.
Oral Medications to Treat Type 2 Diabetes
ADVANCE IN TREATMENT OF TYPE 2 D.M. BY DR : RAMYAHMED SAMY M.D. LECTURER OF INTERNAL MEDICINE BANHA UNIVERSITY
Measuring Success Consortium July 17 th, 2015 Case Study Exploring the COMMUNITY TOOL BOX A demonstration of the CTB’s resources – University of Kansas.
Barriers to Diabetes Control Mark E. Molitch, MD.
Hyperglycemia Management – Medication Therapy
Diabetes Treatments: Options for Insulin Delivery Bonnie Pepon, RN, BSN, CDE Certified Diabetes Educator Conemaugh Diabetes Institute.
The Diabetes Tide John Doig. 228, ,154.
1. SH.ARBABI, M.D Endocrinology Center 18-OCT-2007.
Instructional Design the approach of Robert Gagne ( Conditions of Learning, 1985)
OCAN Train the Trainer For Trainers Version 2.0 December 2010.
Instructional Design JMA503. Objectives 1. Assignments Assignments 2. Project guide Project guide 3. Instructional strategy - Events of instruction. Instructional.
Lesson Plan Essentials
Type 2 diabetes treatment: Old and New Emily Szmuilowicz, MD, MS Assistant Professor of Medicine Division of Endocrinology Northwestern University.
Diabetes Crash Course: The Outpatient Setting Dr. Andrew Schmelz, PharmD Post-Doctoral Teaching Fellow Purdue University October 7, 2008
INSULIN & ORAL HYPOGLYCEMIC AGENTS.
Instructor Development
Diabetes mellitus. Fasting venous plasma glucose ≥ 7mmol/l(126mg/dl) Metabolic disorder, hyperglycemia, abnormality in C.H,fat, protein metabolism. Defect.
Dr. Mansour Alzahrani. متى اكتشف داء السكري؟ داء السكري في الحضارة الهندية والصينية القديمة اسهامات علماء المسلمين في داء السكري.
Oral hypoGLYCEMICS.
Teaching Cross-Cultural Communication Skills Online – A Mixed Method Evaluation of a Novel Curricular Element Amy L. Lee, MD Tufts University School of.
Dr. Sasan Zaeri (PharmD, PhD) Department of Pharmacology, BPUMS.
Medications Used in the Treatment of Diabetes Mellitus
Therapeutics 2 Tutoring
Glycemia Treatment Strategies Used In ACCORD
Miguel A. Parilo, MD, FACP Medical Director,
Gail Bradley MD Community Paramedicine Consortium - West
Objectives Review factors for best therapeutic approach for appropriate pharmacologic choices for diabetes management Review cost implications for.
Shared Decision Making and the Medical Treatment of Type 2 Diabetes
JOT2 – LEARNING THEORIES
Antihyperglycemic Agents and Renal Function
Dr. Sasan Zaeri (PharmD, PhD) Department of Pharmacology, BPUMS
Diabetes Medication Update: Beyond A1c
Recommendation In people with clinical cardiovascular disease in whom glycemic targets are not met, a SGLT2 inhibitor with demonstrated cardiovascular.
The Sweet Talk CSGNA, Victoria BC,21 Sept 2017
Therapeutics Tutoring
Munir Gharaibeh, MD, PhD, MHPE
Diabetes mellitus Prof. Dr. Borvendég János.
Diabetes Medications in the Top 200
Diabetes 101: Myths and Facts
Chapter 13 (Updated November 2016)
Position Statement for People with Types 1 and 2 Diabetes Who Fast during Ramadan Harpreet Singh Bajaj MD, MPH, FACE; Tyceer Abouhassan BEd, MD, MBA,
SGLT2 Inhibitors: What Do the Data Mean for My Patients?
به نام خدا دارو درمانی دیابت
Gagne’s events of Instruction
Sometimes Turtle Feels Upset.
Injectable Options as Add-Ons to Basal Insulin: Targeting PPG in Type 2 Diabetes Patients.
Endocrine Pharmacology
DM management Dr.Duaa Hiasat.
Robert Gagné’s 9 Events of Instruction
Evolution of Insulin: From Human to Analog
eGFR ‘cut-offs’ for glucose lowering therapies
Diabetes mellitus pharmacotherapy
Insulin Delivery Systems Atlanta Diabetes Associates
DM management Dr.Duaa Hiasat.
Oral hypoglycemics Jennifer R Marks, MD.
Renal licences of commonly used anti-diabetes drugs
An insulin simplification regimen: from multiple injections to once-daily long-acting (basal) insulin plus noninsulin agents. *Basal insulins: glargine.
Strategies for Choosing 2nd and 3rd Line Agents in Type 2 Diabetes
Presentation transcript:

hi, folks

troglitazone rosiglitazone albiglutide acarbose exenatide dapagliflozin aspart insulin pioglitazone deglutec insulin saxagliptin tolbutamide detemir insulin linagliptin glipizide glargine insulin canagliflozin chlorpropamide glyburide regular insulin glimepiride NPH insulin miglitol glulisine insulin empagliflozin metformin lispro insulin inhaled insulin alogliptin liraglutide pramlintide repaglinide nateglinide dulaglitide sitagliptin

STEPS criteria to teach therapy choices (and more) Joshua Steinberg MD UHS Wilson Family Medicine Residency SUNY Upstate Medical Univ jds91md@gmail.com

Objectives inform and disseminate about novel approach obtain feedback from fellow educators encourage collaboration on STEPS tables

Teaching Goal Students & residents have a tough time organizing and making choices when faced with an overwhelming number of options 11 categories of HTN meds (maybe 50 meds total) 10 categories of DM2 meds (32 meds plus other interventions) contraception… let’s demonstrate!

make a list of methods

what do women care about?

evaluate a method with STEPS

full STEPS table

more STEPS tables could probably do this with lots of things interventions for depression interventions for hypertension interventions for bipolar start with exhaustive list of interventions/meds or categories of meds ask everyone what criteria would help us see the strengths and weaknesses of options, arrive at STEPS have the group make STEPS table and start to see why which agents shine and which are less good and which no good

Gain Attention Inform Objectives Connect to Prior Knowledge Present Information Provide Guidance Elicit Performance or Practice Provide Feedback Assess Performance Enhance Retention and Transfer recognize they’re overwhelmed, help ‘em overcome make sense of many choices, learn scheme often know most of the content for the grid boxes arrive at options, STEPS scheme, completed grid guide them to STEPS, give tips on options break them up into groups to do a column each lots of feedback as we construct the grid mostly during precepting cases afterwards everyone goes home with grid as handout

Discussion what do you think? do you want to get involved? joshua steinberg jds91md@gmail.com